ClinicalTrials.Veeva

Menu

Comparative Analysis of Isolated Venous, Isolated Arterial, and Standard Access for Transcatheter Closure of Patent Ductus Arteriosus (PDA)

E

Egyptian Biomedical Research Network

Status

Completed

Conditions

Hemodynamically Significant PDA

Treatments

Device: Transcatheter PDA closure

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT06763978
36264PR897/10/24

Details and patient eligibility

About

We enrolled all patients with a hemodynamically significant PDA demonstrated by patient clinical condition, and by PDA size & left chamber dilatation on echocardiography attending at Cardiology Department to we compare the use of a single venous access and a single arterial access with the standard approach requiring both venous and arterial access for transcatheter PDA closure regarding the outcome & complications.

Enrollment

357 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • any patient with hemodynamically significant PDA

Exclusion criteria

  • patient with pulmonary hypertension and Eisenmenger syndrome

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

357 participants in 3 patient groups

152 patients who underwent ordinary transcatheter closure technique using both arterial and venous a
Active Comparator group
Treatment:
Device: Transcatheter PDA closure
113 patients who underwent transcatheter closure using exclusive venous access only.
Active Comparator group
Treatment:
Device: Transcatheter PDA closure
included 92 patients who underwent transcatheter closure using exclusive arterial access only.
Active Comparator group
Treatment:
Device: Transcatheter PDA closure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems